Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Novagali completes phase II study of ophthalmic formulation of ciclosporin

Jan. 17, 2006

Vitragan MAA accepted for review

Jan. 13, 2006

PR Pharmaceuticals and OSI collaborate on sustained-release Macugen

Jan. 13, 2006

iDESTRIN relieves signs and symptoms of dry eye syndrome in postmenopausal women

Jan. 10, 2006

Phase II trial for NT-501 in dry AMD

Jan. 9, 2006

InSite Vision completes debt refinancing to support AzaSite development and filing

Jan. 4, 2006

Genentech submits BLA for Lucentis in wet AMD

Jan. 2, 2006

New beta-adrenoceptor antagonists for eye disorders reported by Othera

Dec. 29, 2005

Animal study begins for Acusolin for cataracts

Dec. 29, 2005

Prostanoid EP4 agonists for ocular disorders emerge from Merck Frosst R&D

Dec. 21, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...